Deutsch English Français

Contact

EP3212759

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP3212759

EP3212759 - CELL CULTURE INSERT [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 30.11.2018 Database last updated on 08.04.2026
Former	Request for examination was made Status updated on 04.08.2017
Former	The international publication has been made Status updated on 05.05.2017
Most recent event Tooltip	14.10.2025	New entry: Renewal fee paid
Applicant(s)	For all designated states Corning Incorporated 1 Riverfront Plaza Corning, New York 14831 / US
	[2017/36]
Inventor(s)	01 / MARTIN, Gregory Roger 227 Peck Road Acton, ME 04001 / US
	02 / TANNER, Allison Jean 380 Greenleaf Avenue Portsmouth, NH 03801 / US
	[2017/36]
Representative(s)	Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
	[N/P]
Former [2017/36]	Scott, Mark Andrew Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
Application number, filing date	15791189.2	29.10.2015
	[2017/36]
	WO2015US58053
Priority number, date	US201462069996P	29.10.2014 Original published format: US 201462069996 P
	[2017/36]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2016069895
	Date:	06.05.2016
	Language:	EN
	[2016/18]
	Type:	A1 Application with search report
	No.:	EP3212759
	Date:	06.09.2017
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 06.05.2016 takes the place of the publication of the European patent application.
	[2017/36]
Search report(s)	International search report - published on:	EP	06.05.2016
Classification	IPC:	C12M1/12, C12M3/00	[2017/36]
	CPC:	C12M25/04 (EP,KR,US); C12M21/08 (EP,KR,US); C12M23/12 (US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/36]
Title	German:	ZELLKULTUREINSATZ	[2017/36]
	English:	CELL CULTURE INSERT	[2017/36]
	French:	INSERT DE CULTURE CELLULAIRE	[2017/36]
Entry into regional phase	18.05.2017	National basic fee paid
	18.05.2017	Designation fee(s) paid
	18.05.2017	Examination fee paid
Examination procedure	04.05.2017	Amendment by applicant (claims and/or description)
	04.05.2017	Date on which the examining division has become responsible
	18.05.2017	Examination requested [2017/36]
	29.11.2018	Despatch of a communication from the examining division (Time limit: M06)
	23.04.2019	Reply to a communication from the examining division
	29.11.2024	Despatch of a communication from the examining division (Time limit: M04)
	26.03.2025	Reply to a communication from the examining division
Fees paid	Renewal fee
	10.10.2017	Renewal fee patent year 03
	08.10.2018	Renewal fee patent year 04
	11.10.2019	Renewal fee patent year 05
	09.10.2020	Renewal fee patent year 06
	08.10.2021	Renewal fee patent year 07
	12.10.2022	Renewal fee patent year 08
	13.10.2023	Renewal fee patent year 09
	11.10.2024	Renewal fee patent year 10
	13.10.2025	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XAY] WO9207063 (COSTAR CORP et al.)
		[Y] WO2014165273 (INNOVATIVE SURFACE TECHNOLOGIES INC et al.)
		[YD] US2010190197 (MARTIN GREGORY R et al.)
		[A] US2014106394 (KO EUN et al.)
	by applicant	US8163537
		LAU ET AL., DRUG METABOLISM AND DISPOSITION, vol. 32, no. 9, 2004, pages 937 - 942
		CHOI ET AL., TOXICOLOGY IN VITRO, vol. 18, 2004, pages 393 - 402
		U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES ET AL.,: ""Guidance for Industry: Drug Interaction Studies-Study, Design, Data Analysis, and Implications for Dosing and Labeling",", September 2006, CLINICAL PHARMACOLOGY

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.